T. Rowe Price
is among those in talks to
purchase a stake in India's third largest money management
firm, UTI Asset Management Co.
, The Wall Street Journal's
John Satish Kumar and Shefali Anand report in
Tuesday's Fund Track column
A T. Rowe spokesman declined to comment.
UTI's chief marketing officer, Jaideep Bhattacharya, said his company is in discussions with many foreign firms and one domestic player. UTI is looking to sell a stake of as much as 26 percent.
Besides T. Rowe, another U.S.-based fund firm's name cropped up as a possible purchaser of the stake. The Press Trust of India reported that Vanguard
in UTI, which ended November with AUM of $383.58 rupees ($7.92 billion). A Vanguard spokeswoman, however, said the company is not looking into buying a stake in UTI, nor has it held any talks with the latter.
The Press Trust of India also named Japan's Shinsei Bank as a a possible strategic partner for UTI.
U.S.-based asset managers that have subsidiaries in India include Fidelity and Franklin Templeton.
Stay ahead of the news ... Sign up for our email alerts now